Schonfeld Strategic Advisors LLC Reneo Pharmaceuticals, Inc. Call Options Transaction History

Schonfeld Strategic Advisors LLC

  • $15.4 Billion
  • Q4 2024

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.34 - $8.43 $13,400 - $84,300
10,000 New
10,000 $16,000

Others Institutions Holding RPHM

# of Institutions
3
Shares Held
4.9M
Call Options Held
0
Put Options Held
0
View Full List

About Reneo Pharmaceuticals, Inc.

RPHM Quotes by TradingView
  • Ticker RPHM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,479,600
  • Market Cap $41.1M
  • Description
  • Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...
More about RPHM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email